SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-17-004468
Filing Date
2017-05-11
Accepted
2017-05-11 17:17:36
Documents
2
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A vtgn10qaam2_dec312016.htm 10-Q/A 46864
2 EXCLUSIVE LICENSE AND SUBLICENSE AGREEMENT ex10-1.htm EX-10.1 1053147
  Complete submission text file 0001654954-17-004468.txt   1101117
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-37761 | Film No.: 17835452
SIC: 2834 Pharmaceutical Preparations